Get started
Author

Yannis Morel

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
2018 · Pascale André, Caroline Denis, et al. · Cell · 1,249
Harnessing innate immunity in cancer therapy
2019 · Olivier Demaria, Stéphanie Cornen, et al. · Nature · 971
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
2020 · Julien Carvelli, Olivier Demaria, et al. · Nature · 530
PDF
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
2007 · Thierry Walzer, Mathieu Bléry, et al. · Proceedings of the National Academy of Sciences · 496
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
2019 · Laurent Gauthier, Ariane Morel, et al. · Cell · 451
PDF
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
2019 · Ivan Perrot, Henri-Alexandre Michaud, et al. · Cell Reports · 439
PDF
Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides
2006 · Sandra S. Diebold, Catherine Massacrier, et al. · European Journal of Immunology · 287
PDF
Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma
2005 · Emilie Viey, Gaëlle Fromont, et al. · The Journal of Immunology · 209
PDF
Reciprocal Expression of the TNF Family Receptor Herpes Virus Entry Mediator and Its Ligand LIGHT on Activated T Cells: LIGHT Down-Regulates Its Own Receptor
2000 · Yannis Morel, Jean-Marc Schiano de Colella, et al. · The Journal of Immunology · 179
The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity
2001 · Yannis Morel, Alemseged Truneh, et al. · The Journal of Immunology · 175
TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
2011 · Bruno Salaun, Laurence Zitvogel, et al. · Cancer Research · 129
TLR3 and Rig-Like Receptor on Myeloid Dendritic Cells and Rig-Like Receptor on Human NK Cells Are Both Mandatory for Production of IFN-γ in Response to Double-Stranded RNA
2010 · Ivan Perrot, Florence Deauvieau, et al. · The Journal of Immunology · 115
PDF
Plasmacytoid dendritic cell–derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists
2010 · Deepa Rajagopal, Carine Paturel, et al. · Blood · 115
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123
2023 · Laurent Gauthier, Angela Virone-Oddos, et al. · Nature Biotechnology · 112
PDF
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide
2014 · I. S. Nijhof, J. J. L. van Bueren, et al. · Haematologica · 112
PDF
Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
2010 · Rosa Conforti, Yuting Ma, et al. · Cancer Research · 111
Desirable cell death during anticancer chemotherapy
2010 · Clara Locher, Rosa Conforti, et al. · Annals of the New York Academy of Sciences · 84
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
2022 · Olivier Demaria, Laurent Gauthier, et al. · Cell Reports Medicine · 78
PDF
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
2020 · Olivier Demaria, Julien Carvelli, et al. · Cellular and Molecular Immunology · 77
PDF
The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
2013 · Nassima Oumata, Phu hai Nguyen, et al. · PLoS ONE · 32
PDF
483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
2020 · Olivier Demaria, Julien Carvelli, et al. · Journal for ImmunoTherapy of Cancer · 30
PDF
Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
2010 · Luc Friboulet, Claire Gourzones, et al. · BMC Cancer · 28
PDF
Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic
2012 · Benjamin Vérillaud, Mélanie Gressette, et al. · Infectious Agents and Cancer · 24
PDF
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
2024 · Olivier Demaria, Guillaume Habif, et al. · Science Immunology · 22
Mechanisms Regulating Expression of the Tumor Necrosis Factor-related light Gene
2002 · Rémy Castellano, Carine Van Lint, et al. · Journal of Biological Chemistry · 22
Works count: 69
Citation count: 6,236
H-index: 23
I10-index: 31
Year
Topic
Type